Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Neuroleptic agent

Chemical Name

10H-Phenotiazine-2-carbonitrile, 10-[3-(4-hydroxy-1-piperidinyl)propyl]-

Foreign Names

  • Periciazinum (Latin)
  • Periciazin (German)
  • Périciazine (French)
  • Periciazina (Spanish)

Generic Names

  • Periciazina (OS: DCIT)
  • Pericyazine (OS: BAN)
  • Propericiazine (OS: JAN)
  • Propériciazine (OS: DCF)
  • Bayer 1409 (Bayer) (IS)
  • RP 8909 (IS)
  • SKF 20716 (IS)

Brand Names

  • Nemactil
    Sanofi-Aventis, Spain
  • Neulactil
    Sanofi, Denmark; Sanofi Oy, Finland; Sanofi-Aventis, Australia; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, New Zealand
  • Neuleptil
    A. Nattermann, Russian Federation; A. Nattermann & Cie, Israel; ERFA Canada, Canada; IFET, Greece; Sanofi Aventis, Chile; Sanofi Aventis, Tunisia; Sanofi-Aventis, France; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Paraguay; Sanofi-Aventis, Uruguay; Sanofi-Aventis, Venezuela; Sanofi-Aventis Farmaceutica, Brazil; Sanofi-Aventis Group, Russian Federation; Sanofi-Aventis Netherlands, Netherlands; Takata Pharmaceutical, Japan; Teofarma, Italy
  • Neuleptil 1%
    Sanofi-Aventis, France; Takata Pharmaceutical, Japan
  • Neuleptil 10%
    Takata Pharmaceutical, Japan
  • Neuleptil 10mg
    Famar, Israel
  • Neuleptil 4%
    IFET, Greece; Sanofi-Aventis, France
  • Periciazina
    AC Farma, Peru
  • Pericyazine
    Zentiva, United Kingdom
  • Propexol
    AC Farma, Peru


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.